Baldwin M - Search Results

1

Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France.

Chouaid C, Germain N, De Pouvourville G, Aballéa S, Korchagina D, Baldwin M, Le Lay K, Luciani L, Toumi M, Devillier P. Chouaid C, et al. Among authors: baldwin m. Curr Med Res Opin. 2019 May;35(5):785-792. doi: 10.1080/03007995.2019.1574507. Epub 2019 Feb 15. Curr Med Res Opin. 2019. PMID: 30681007

2

Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results.

Hoogendoorn M, Corro Ramos I, Baldwin M, Luciani L, Fabron C, Detournay B, Rutten-van Mölken MPMH. Hoogendoorn M, et al. Among authors: baldwin m. Int J Chron Obstruct Pulmon Dis. 2019 Feb 18;14:447-456. doi: 10.2147/COPD.S191031. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 30863045 Free PMC article.

3

Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine.

Hoogendoorn M, Corro Ramos I, Baldwin M, Gonzalez-Rojas Guix N, Rutten-van Mölken MPMH. Hoogendoorn M, et al. Among authors: baldwin m. Value Health. 2019 Mar;22(3):313-321. doi: 10.1016/j.jval.2018.10.008. Epub 2018 Dec 20. Value Health. 2019. PMID: 30832969 Free article.

4

Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.

Selya-Hammer C, Gonzalez-Rojas Guix N, Baldwin M, Ternouth A, Miravitlles M, Rutten-van Mölken M, Goosens LM, Buyukkaramikli N, Acciai V. Selya-Hammer C, et al. Among authors: baldwin m. Ther Adv Respir Dis. 2016 Oct;10(5):391-401. doi: 10.1177/1753465816657272. Epub 2016 Jul 12. Ther Adv Respir Dis. 2016. PMID: 27405723 Free PMC article.

5

Improving clinical reality in chronic obstructive pulmonary disease economic modelling : development and validation of a micro-simulation approach.

Asukai Y, Baldwin M, Fonseca T, Gray A, Mungapen L, Price D. Asukai Y, et al. Among authors: baldwin m. Pharmacoeconomics. 2013 Feb;31(2):151-61. doi: 10.1007/s40273-012-0016-3. Pharmacoeconomics. 2013. PMID: 23329431 Free PMC article.

6

Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis.

Schlueter M, Gonzalez-Rojas N, Baldwin M, Groenke L, Voss F, Reason T. Schlueter M, et al. Among authors: baldwin m. Ther Adv Respir Dis. 2016 Apr;10(2):89-104. doi: 10.1177/1753465815624612. Epub 2016 Jan 8. Ther Adv Respir Dis. 2016. PMID: 26746383 Free PMC article. Review.

7

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.

Gruffydd-Jones K, Brusselle G, Jones R, Miravitlles M, Baldwin M, Stewart R, Rigazio A, Davis E, Keininger DL, Price D. Gruffydd-Jones K, et al. Among authors: baldwin m. NPJ Prim Care Respir Med. 2016 Feb 25;26:16002. doi: 10.1038/npjpcrm.2016.2. NPJ Prim Care Respir Med. 2016. PMID: 28358398 Free PMC article.

8

Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT^® Re-usable Inhaler.

Ortsäter G, Borgström F, Baldwin M, Miltenburger C. Ortsäter G, et al. Among authors: baldwin m. Appl Health Econ Health Policy. 2020 Jun;18(3):433-442. doi: 10.1007/s40258-019-00540-0. Appl Health Econ Health Policy. 2020. PMID: 31808066 Free PMC article.

9

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.

Olson AL, Hartmann N, Patnaik P, Garry EM, Bohn RL, Singer D, Baldwin M, Wallace L. Olson AL, et al. Among authors: baldwin m. Adv Ther. 2022 Apr;39(4):1794-1809. doi: 10.1007/s12325-022-02066-9. Epub 2022 Feb 23. Adv Ther. 2022. PMID: 35199282 Free PMC article.

10

The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease.

Swigris J, Cutts K, Male N, Baldwin M, Rohr KB, Bushnell DM. Swigris J, et al. Among authors: baldwin m. ERJ Open Res. 2021 May 24;7(2):00145-2020. doi: 10.1183/23120541.00145-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 34046493 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,038 results

Search Page